2022 - Pharmacist Digest

GPhC November pass rate drops again to 2022 levels

The Pharmacist

DECEMBER 17, 2024

This brings the pass rates back down almost to November 2022 levels of 56%, following a 10% rise to 66% in November 2023. And it comes as summer pass rates have seen a steady decline […] The post GPhC November pass rate drops again to 2022 levels appeared first on The Pharmacist.

Diabetes

More than 50 Access Scheme pharmacies have closed since 2022, NPA claims

The Pharmacist

JANUARY 2, 2025

This represents 4% of the 1,444 pharmacies eligible to claim funding under the scheme set up to 'capture the pharmacies that are most important for patient access, those […] The post More than 50 Access Scheme pharmacies have closed since 2022, NPA claims appeared first on The Pharmacist.

U.S. government spent more on health care in 2022 than six countries with universal health care combined

STAT

DECEMBER 19, 2023

trillion in federal and state health care expenditures in 2022 — about 41% of the nearly $4.5 American taxpayers footed the bill for at least $1.8 trillion in both public and private health care spending the U.S. recorded last year, according to the annual report released last week by the Centers for Medicare and Medicaid Services.

Opinion: Herding cats: It’s past time to include pets in disease surveillance

STAT

MARCH 4, 2025

Since 2022, more than 100 domesticated cats in the United States have had confirmed infections — some house pets, some barn cats, some feral — with high mortality, although mortality data remain undocumented on federal sites.

STAT+: AbbVie snaps up CAR-T company in a deal worth $2.1 billion

STAT

JUNE 30, 2025

Capstan launched in 2022 and has raised around $340 million from OrbiMed, Vida Ventures, RA Capital, Polaris Partners, and the venture teams at Pfizer, Bayer, Eli Lilly and Company, and Bristol Myers Squibb. AbbVie will pay up to $2.1 billion in cash when the deal closes, according to a press release.

STAT+: FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system

STAT

JANUARY 14, 2025

billion in revenue by dispensing medicines to treat cancer, HIV, heart disease and other serious illnesses at prices that exceeded their estimated acquisition costs between 2017 and 2022. Specifically, the companies were able to generate more than $7.3 Continue to STAT+ to read the full story…

Drug Pricing

Drug Pricing Drug Development

STAT+: The prices of 8 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2022, report finds

STAT

DECEMBER 11, 2023

During 2022, drugmakers substantially raised prices on eight widely used medicines without any new clinical evidence to justify the increases, leading patients and health insurers in the U.S. to spend an additional $1.2 billion last year, according to a new report.

Drug Pricing

STAT+: AstraZeneca says China has detained a senior executive

STAT

NOVEMBER 6, 2024

Before joining Beigene in January 2022, Yin had worked for AstraZeneca for more than 15 years and was general manager of its oncology business in China. The individuals, who were detained last summer, are all Chinese citizens who marketed drugs in the oncology division. Continue to STAT+ to read the full story…

STAT+: Pfizer to pay $60 million to settle claims that Biohaven paid kickbacks to doctors

STAT

JANUARY 24, 2025

The authorities alleged that, from March 2020 through September 2022, Biohaven improperly paid doctors speaking fees and for meals at “high end” restaurants in order to persuade them to prescribe Nurtec ODT, the centerpiece of the $11.6 Department of Justice. billion acquisition.

U.S. life expectancy rose in 2022, but it remains below its pre-pandemic level

STAT

NOVEMBER 29, 2023

The 2022 rise was mainly due to the waning pandemic, Centers for Disease Control and Prevention researchers said Wednesday. NEW YORK — U.S. life expectancy rose last year — by more than a year — but still isn’t close to what it was before the Covid-19 pandemic. But even with the large increase, U.S.

Heart failure market to grow at 9.6 per cent CAGR in 7MM during 2022-32

Express Pharma

JANUARY 7, 2025

billion in 2022 to $33.7 per cent CAGR in 7MM during 2022-32 appeared first on Express Pharma. With pipeline approvals of varying mechanisms of action and an influx of newly diagnosed patients, the heart failure (HF) market is expected to grow at a 9.6 per cent compound annual growth rate (CAGR) from $13.5

Compounding

Compounding Pharmaceutical Companies Pharmaceutical Companies

STAT+: Congress nears deal to rein in PBMs after years of debate

STAT

DECEMBER 16, 2024

Passage of laws to address pharmacy middlemen has been the top priority of the pharmaceutical industry, particularly after they suffered a stinging defeat when Democrats passed their drug pricing law in 2022. The pharma industry spent millions on advertising to promote PBM legislation, and it appears it will get most of what it wanted.

Packaging

Packaging Drug Pricing

RFK Jr. calls rising autism rate an ‘epidemic.’ Researchers call it a ‘good sign’

STAT

APRIL 15, 2025

of kids surveyed in 2022 have autism spectrum disorder, a slight uptick from the 2.8% But health secretary Robert F. Kennedy Jr. instead has pointed to the data as evidence of a growing crisis. The Centers for Disease Control and Prevention report says that 3.2% of kids surveyed in 2020 for the previous report.

Opinion: I’m the director of the Center for Medicare. Here’s how we executed the first round of drug price negotiation

STAT

OCTOBER 29, 2024

The historic Inflation Reduction Act of 2022 has fundamentally improved the affordability of and access to prescription drugs for millions of people with Medicare. The law laid out aggressive timelines for implementing the Medicare Drug Price Negotiation Program.

Drug Pricing

STAT+: Sutter Health settles sweeping antitrust case, narrowly avoiding trial

STAT

MARCH 3, 2025

In 2022, a U.S. The long-running federal lawsuit was settled on the eve of trial on Sunday. It would have been the second time the case, Sidibe v. Sutter Health, was tried before a jury. appeals court determined that a judge’s error caused the jury to miss out on crucial details and overturned Sutter’s win.

Hospitals

Mayo Clinic’s partnership with dairy poses conflict of interest, critics say

STAT

MARCH 10, 2025

In 2022, the Mayo Clinic signed a five-year partnership with the dairy checkoff, a program overseen by the U.S. But a partnership between the dairy industry and the Mayo Clinic, one of the top-ranked health systems in the U.S., is drawing criticism for its potential to undermine the Minnesota powerhouse’s credibility.

Mayo Clinic

Mayo Clinic Communication Hospitals

STAT+: Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition

STAT

APRIL 15, 2024

Ultragenyx has found early success with its experimental treatment for the rare disease Angelman syndrome, supporting the company’s decision to acquire its development partner two years ago.

Communication

STAT+: Biotech accelerator Curie.Bio raises $340 million for a new seed fund

STAT

JANUARY 29, 2025

Since 2022, Curie.Bio has received some 4,000 applications. Borisy and Weinberg’s firm was created to upend the biotech financing model , offering both capital and expert assistance to founders seeking on option outside of traditional VC funding. It has invested in 26 startups, giving it a less than 1% acceptance rate.

Drug Development

STAT+: Health care CEOs dialed back their pay in 2023. They still made $3.5 billion

STAT

SEPTEMBER 30, 2024

billion combined last year, compared with $4 billion in 2022. million in 2022. But the biggest names in health care still made $3.5 The average chief executive brought home $11 million, while the median was $4.1 Those figures compared to an average of $13 million and median of $4.3

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Hospitals

STAT+: Health tech investments are picking up steam. Here are 5 VC leaders behind the biggest recent deals

STAT

OCTOBER 30, 2024

Health tech investments are showing signs of resilience following the perilous lows of 2022 and 2023: Just this past month, two startups that analysts believe might be getting ready for IPOs raised more than $100 million in late-stage funding rounds.

Diabetes

Routine vaccinations drop among U.S. kindergartners for the third year in a row

STAT

JANUARY 12, 2023

kindergartners who’ve received standard childhood vaccines took a small but notable dip into the 2021-2022 school year, health officials said Thursday, amid disruptions related to Covid-19 and fears that anti-vaccine sentiment stirred up by the pandemic could be spreading to other shots. The percentage of U.S.

Vaccines

What will it take to end health care worker burnout?

STAT

OCTOBER 26, 2023

Researchers compared survey data from 2018 and 2022, finding that health workers experienced poorer mental health outcomes post-pandemic. Of those surveyed, 46% of health workers reported feeling burnout often or very often in 2022, compared to 32% in 2018. Read the rest…

Hospitals

STAT+: As more patients get automated test results, researchers seek ways to calm their nerves

STAT

APRIL 8, 2025

When he walked into his cancer patient’s visit in 2022, he was wearing a big smile: The nodules in his patient’s lungs, he saw in the radiology report, were shrinking in response to treatment. Editor’s note: This story contains a description of self-harm. Oncologist Mark Lewis has never had much of a poker face.

STAT+: Appeals court reopens the question of who owns patents for groundbreaking CRISPR discovery

STAT

MAY 12, 2025

In 2022, the U.S. Court of Appeals for the Federal Circuit sided with the University of California and the University of Vienna in their bid to revive a fight over foundational CRISPR-Cas9 patents that the schools say should go to their Nobel Prize-winning scientists Jennifer Doudna and Emmanuelle Charpentier.

Antiviral used for mpox no better than placebo, NIH says

STAT

AUGUST 15, 2024

The results are notable because the drug, tecovirimat, has rarely been studied clinically for mpox, despite its sporadic use over the years in parts of Africa and its wider use during the 2022 and 2023 outbreaks in the U.S. and Europe. Read the rest…

Lyme disease cases rise, but largely due to a change in data collection

STAT

FEBRUARY 15, 2024

A new report released Thursday by the Centers for Disease Control and Prevention appears to show that Lyme disease cases in the United States rose by 69% in 2022 over previous years. The change, an attempt to lift a crushing reporting burden off the shoulders of states where Lyme disease infections are common, went into effect in 2022.

STAT+: Amid a rough biotech job market, fewer biomedical Ph.D. grads head for industry, data show

STAT

OCTOBER 10, 2024

in 2022, breaking a decade-long trend of nearly continuous annual increases in the share of graduates headed for the private sector. in 2022 to 22.1%. in 2022 and 66% in 2021. in 2022 and 66% in 2021. That’s a sizable dip from 66.5% That trend suggests that among Ph.D.

The U.S. hasn’t seen syphilis numbers this high since 1950. Other STD rates are down or flat

STAT

JANUARY 30, 2024

syphilis epidemic isn’t abating, with the rate of infectious cases rising 9% in 2022, according to a new federal government report on sexually transmitted diseases in adults. NEW YORK — The U.S. But there’s some unexpected good news: The rate of new gonorrhea cases fell for the first time in a decade.

STAT’s Inaugural Diversity Report and Commitment to a Workplace of Diversity and Inclusion

STAT

JULY 6, 2023

Here, we share the self-reported gender and racial/ethnic demographics of our staff from STAT’s inception in 2015 through 2022. In 2022, they made up a majority of the company and management. The percentage of managers who are people of color remains the same in 2022 as it was in 2015, at 20%. population.

STAT+: Pharma execs donated more to Democrats in campaign’s final stretch

STAT

OCTOBER 21, 2024

30, five gave to Democratic candidates, even though Democratic lawmakers passed the most aggressive drug pricing reform in decades in 2022. But of the six executives who donated to individual candidates between July 1 and Sept. Continue to STAT+ to read the full story…

Drug Pricing

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies

STAT+: How to tell if Biden drove a hard bargain on drug prices

STAT

JULY 30, 2024

In 2022, Democrats directed Medicare to negotiate drug prices for the first time as part of the Inflation Reduction Act. billion in out-of-pocket costs for an estimated 9 million Medicare enrollees in 2022, according to the Biden administration. Here are four ways to tell whether the Biden administration got a good deal.

Drug Pricing

STAT+: More HHS cuts, and DOJ seeks to recoup loans from Medicaid fraudster

STAT

MARCH 31, 2025

A double whammy for fraudsters In 2022, a 58-year-old Idaho woman was jailed and ordered to repay over $200,000 for defrauding Idaho’s Medicaid program. More government layoffs, a national security leak, and everyone’s mad about The Bachelor’s pick. Let’s catch you up.

Drug Development

Drug Development Hospitals

Is there a nursing shortage in the United States? Depends on who you ask

STAT

OCTOBER 16, 2023

In 2022, the American Hospital Association quoted an estimate that half a million nurses would leave the field by the end of that year, bringing the total shortage to 1.1 Hospitals are frustrated with a nationwide nursing shortage that’s only gotten worse since the pandemic.

Hospitals

STAT+: PhRMA dues fell almost $100 million as major drugmakers exited

STAT

DECEMBER 23, 2024

WASHINGTON — Three large pharmaceutical companies left the brand-drug lobby PhRMA after the passage of Democrats’ drug pricing law in 2022. Following the exits, the organization collected $100 million less in annual membership dues, new tax filings show. Continue to STAT+ to read the full story…

Drug Pricing

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies

After Amylyx drug failure, what’s next for ALS?

PharmaVoice

MARCH 15, 2024

The company’s combo treatment Relyvrio was approved in 2022, but after failing a phase 3 trial, may be pulled from the market.

In the era of GLP-1 drugs, demand for bariatric surgery plunges

STAT

OCTOBER 25, 2024

It found that between 2022 and 2023, as prescriptions for GLP-1 drugs more than doubled, rates of bariatric surgery fell by 25.6%. Read the rest…

Hospitals

STAT+: How biotech deal-making really works behind the scenes, according to founders

STAT

OCTOBER 20, 2023

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6

STAT+: GSK blood cancer therapy, once pulled from the market, is approved in the U.K.

STAT

APRIL 17, 2025

and other countries, but GSK pulled it from the market in 2022 after the drug failed in a study meant to confirm its benefit. Blenrep had previously been approved in the U.S., European Union, U.K., Continue to STAT+ to read the full story…

More than 1 billion people have obesity, including 159 million young people, study estimates

STAT

FEBRUARY 29, 2024

Obesity rates grew particularly fast among children and teens, quadrupling from 1990 to 2022, the latest year the analysis looked at, while rates among adults more than doubled. More than 1 billion people — or one in eight people worldwide — are now estimated to have obesity, a new study finds.

Opinion: Hospital care costs are out of control. Price caps can help

STAT

APRIL 4, 2024

trillion in 2022 , finding ways to cut costs has become increasingly urgent. Private health insurance premiums paid by working age adults are rising rapidly. Many Americans skip necessary medical care, while those who do get treated can end up bankrupt. health care spending reaching $4.5 Read the rest…

Hospitals

Scientists spot an orangutan using a plant to treat his own wound in the wild

STAT

MAY 2, 2024

Which is likely how Rakus, an adult male orangutan frequently seen in Gunung Leuser National Park in South Aceh, Indonesia, acquired a face wound in June 2022. Things can get tense.

Researchers try to tease out possible ties between long Covid and menopause

STAT

OCTOBER 20, 2023

When she stopped getting her period in March 2022, Daryn Schwartz wasn’t especially concerned. At 42, she had recently come off birth control, and figured her cycles were still adjusting. When it hadn’t come back by the summer, she sought gynecological care, but was told to wait it out. So she did, with no changes.

Surge of respiratory disease in China triggers anxiety, but experts see likely explanation

STAT

NOVEMBER 23, 2023

China only lifted that diktat — and eased the draconian restrictions that made it work — in late 2022. Read the rest…

Long Covid is more prevalent among Americans with disabilities, new CDC data show

STAT

JULY 16, 2024

The data, gathered in 2022, is part of the agency’s Disability and Health Data System , which has annual state and national-level data stretching back to 2016. This slice of the population was also much more likely to report long Covid symptoms such as chronic fatigue and brain fog.

GPhC November pass rate drops again to 2022 levels

More than 50 Access Scheme pharmacies have closed since 2022, NPA claims

Trending Sources

U.S. government spent more on health care in 2022 than six countries with universal health care combined

Opinion: Herding cats: It’s past time to include pets in disease surveillance

STAT+: AbbVie snaps up CAR-T company in a deal worth $2.1 billion

STAT+: FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system

STAT+: The prices of 8 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2022, report finds

STAT+: AstraZeneca says China has detained a senior executive

STAT+: Pfizer to pay $60 million to settle claims that Biohaven paid kickbacks to doctors

U.S. life expectancy rose in 2022, but it remains below its pre-pandemic level

Heart failure market to grow at 9.6 per cent CAGR in 7MM during 2022-32

STAT+: Congress nears deal to rein in PBMs after years of debate

RFK Jr. calls rising autism rate an ‘epidemic.’ Researchers call it a ‘good sign’

Opinion: I’m the director of the Center for Medicare. Here’s how we executed the first round of drug price negotiation

STAT+: Sutter Health settles sweeping antitrust case, narrowly avoiding trial

Mayo Clinic’s partnership with dairy poses conflict of interest, critics say

STAT+: Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition

STAT+: Biotech accelerator Curie.Bio raises $340 million for a new seed fund

STAT+: Health care CEOs dialed back their pay in 2023. They still made $3.5 billion

STAT+: Health tech investments are picking up steam. Here are 5 VC leaders behind the biggest recent deals

Routine vaccinations drop among U.S. kindergartners for the third year in a row

What will it take to end health care worker burnout?

STAT+: As more patients get automated test results, researchers seek ways to calm their nerves

STAT+: Appeals court reopens the question of who owns patents for groundbreaking CRISPR discovery

Antiviral used for mpox no better than placebo, NIH says

Lyme disease cases rise, but largely due to a change in data collection

STAT+: Amid a rough biotech job market, fewer biomedical Ph.D. grads head for industry, data show

The U.S. hasn’t seen syphilis numbers this high since 1950. Other STD rates are down or flat

STAT’s Inaugural Diversity Report and Commitment to a Workplace of Diversity and Inclusion

STAT+: Pharma execs donated more to Democrats in campaign’s final stretch

STAT+: How to tell if Biden drove a hard bargain on drug prices

STAT+: More HHS cuts, and DOJ seeks to recoup loans from Medicaid fraudster

Is there a nursing shortage in the United States? Depends on who you ask

STAT+: PhRMA dues fell almost $100 million as major drugmakers exited

After Amylyx drug failure, what’s next for ALS?

In the era of GLP-1 drugs, demand for bariatric surgery plunges

STAT+: How biotech deal-making really works behind the scenes, according to founders

STAT+: GSK blood cancer therapy, once pulled from the market, is approved in the U.K.

More than 1 billion people have obesity, including 159 million young people, study estimates

Opinion: Hospital care costs are out of control. Price caps can help

Scientists spot an orangutan using a plant to treat his own wound in the wild

Researchers try to tease out possible ties between long Covid and menopause

Surge of respiratory disease in China triggers anxiety, but experts see likely explanation

Long Covid is more prevalent among Americans with disabilities, new CDC data show

Stay Connected